Mycobacterium Smegmatis
M. smegmatis re1A homolog affects cell appearance/viability/gene expression
Published in Medical Letter on the CDC and FDA, June 19th, 2005
"The modification of metabolic pathways to allow for a dormant lifestyle appears to be an important feature for the survival of pathogenic bacteria within their host. One regulatory mechanism for persistent Mycobacterium tuberculosis infections is the stringent response.
"In this study, we analyze the stringent response of a nonpathogenic, saprophytic mycobacterial species, Mycobacterium smegmatis," researchers in the United States report.
"The use of M. smegmatis as a tool for studying the mycobacterial...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Buruli Ulcer Disease
Risk factors for Buruli ulcer disease outlined - Cancer Pathogenesis
Liver sensitivity to nitrosourea mutagenicity is age dependent - Liver Cancer
Hepatitis B infections in hepatitis C-associated liver cancer examined - Pregnancy
Homicide is leading cause of injury deaths among pregnant women in U.S. - Stroke
Greater prevention efforts needed, especially in African Americans - Alcohol Use
Health behaviors help physicians identify women more likely to have been abused - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
